coronavirus
respiratori
virus
whose
appear
electron
microscopi
look
like
tini
crown
figur
first
coronavirus
discov
caus
pediatr
adult
respiratori
infect
particularli
danger
one
studi
vanderbilt
found
coronaviru
sampl
upper
respiratori
ill
lower
respiratori
ill
clinic
signific
coronaviru
infect
found
children
year
age
review
journal
although
adult
also
might
suffer
sever
infect
pictur
late
group
respiratori
virus
could
caus
seriou
ill
young
neglig
mortal
two
event
chang
pictur
discoveri
middl
eastern
respiratori
syndrom
mer
explos
outbreak
sever
acut
respiratori
syndrom
sar
mer
caus
respiratori
ill
dromedari
transmit
human
infect
seriou
fatal
moreov
serolog
studi
show
mer
infect
common
saudi
arabia
contact
camel
common
also
humantohuman
infect
occur
sever
candid
vaccin
mer
develop
intern
organ
coalit
epidem
prepared
cepi
see
well
known
sar
caus
highli
fatal
infect
human
research
latter
viru
conclud
sar
like
viru
reservoir
bat
infect
small
mammal
palm
civet
latter
consid
delicaci
eat
chines
sold
mani
market
china
sourc
sar
thought
market
guandong
howev
receptor
coronaviru
present
human
lung
direct
infect
bat
may
possibl
bat
coronaviru
isol
genet
close
sar
although
sar
longer
circul
human
candid
vaccin
develop
never
licens
natur
frequent
repeat
new
coronaviru
name
sar
coronaviru
escap
market
citi
wuhan
central
china
spread
although
mortal
seem
lower
case
sar
mani
infect
caus
lower
respiratori
tract
diseas
requir
hospit
although
yet
confirm
write
like
origin
infect
transfer
small
mammal
wuhan
market
human
case
spread
humantohuman
contact
respiratori
secret
infect
individu
contain
viru
evid
viru
may
excret
stool
obvious
much
inform
unpublish
exchang
world
health
organ
websit
sequenc
show
homolog
sar
crossneutr
sar
antiserum
probabl
enough
use
protect
human
popul
inform
new
viru
evolv
rapidli
laboratori
throughout
world
work
hard
among
critic
question
grow
viru
grow
cell
cultur
antibodi
viru
protect
enhanc
anim
model
use
studi
viru
antibodi
sar
mer
protect
best
vaccin
antigen
whole
viru
spike
protein
receptorbind
domain
spike
protein
larg
amount
vaccin
made
next
winter
assum
becom
season
threat
obviou
reason
singledos
vaccin
would
prefer
vaccin
requir
sever
dose
current
focu
develop
antibodi
spike
surfac
protein
particular
receptorbind
domain
protein
obviou
platform
develop
singledos
vaccin
attenu
virus
dna
plasmid
messeng
rna
construct
code
viral
protein
stimul
neutral
antibodi
howev
subunit
protein
vaccin
also
develop
appear
emphas
new
agent
emerg
time
time
threaten
human
mechan
rapid
respons
place
beforehand
reason
cepi
develop
inde
cepi
togeth
marshal
largescal
prevent
therapeut
respons
new
viru
asid
develop
vaccin
step
chines
govern
take
ban
sale
small
mammal
market
prevent
introduct
coronavirus
matter
pathogen
gener
could
adapt
human
potenti
conflict
interest
dr
plotkin
consult
mani
vaccin
manufactur
biotechnolog
organ
author
submit
icmj
form
disclosur
potenti
conflict
interest
conflict
editor
consid
relev
content
manuscript
disclos
